Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China · Delayed Price · Currency is CNY 59.88
+1.45 (2.48%)
At close: Sep 14, 2026
SHE:301093 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 608.73 | 619.45 | 586.41 | 622.92 | 584.14 | 820.87 |
Revenue Growth | -0.44% | 5.63% | -5.86% | 6.64% | -28.84% | 83.92% |
Gross Profit Gross Profit Growth | 233.08 | 237.46 | 222.76 | 255.36 | 250 | 447.02 |
Operating Income Operating Income Growth | 11.83 | 50.11 | 33.18 | 71.68 | 66.3 | 252.34 |
Net Income Net Income Growth | 24.12 | 60.18 | 49.57 | 117.93 | 93.75 | 216.02 |
Earnings Per Share EPS Growth | 0.12 | 0.28 | 0.23 | 0.51 | 0.41 | 1.20 |
EPS Growth | -53.63% | 23.17% | -55.32% | 24.57% | -65.65% | 151.39% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 |
Medicine Manufacturing Medicine Manufacturing Growth | 615.96 | 584.36 | 621.2 | 583.63 |
Others Others Growth | 3.5 | 2.06 | 1.72 | 0.51 |
Total Total Growth | 619.45 | 586.41 | 622.92 | 584.14 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 1,237 | 1,280 | 1,299 | 1,580 | 1,669 | 1,872 |
Total Debt Total Debt Growth | 133.99 | 90.75 | 1.23 | - | - | 41.18 |
Net Cash (Debt) Net Cash Growth | 1,103 | 1,189 | 1,297 | 1,580 | 1,669 | 1,831 |
Net Cash Growth | -13.77% | -8.36% | -17.88% | -5.31% | -8.87% | - |
Net Cash Per Share Net Cash Per Share Growth | 5.52 | 5.58 | 6.00 | 6.87 | 7.33 | 10.16 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 89.29 | 115.49 | 120.78 | 223.85 | 94.88 | 216.54 |
Capital Expenditures CapEx Growth | -123.85 | -132.59 | -135.43 | -297.25 | -173.62 | -123.76 |
Free Cash Flow Free Cash Flow Growth | -34.56 | -17.09 | -14.65 | -73.39 | -78.73 | 92.78 |
Free Cash Flow Growth | - | - | - | - | - | -1.15% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 38.29% | 38.33% | 37.99% | 40.99% | 42.80% | 54.46% |
Operating Margin | 1.94% | 8.09% | 5.66% | 11.51% | 11.35% | 30.74% |
Pretax Margin | 4.23% | 11.16% | 9.98% | 22.04% | 18.37% | 30.82% |
Profit Margin | 3.96% | 9.71% | 8.45% | 18.93% | 16.05% | 26.32% |
FCF Margin | -5.68% | -2.76% | -2.50% | -11.78% | -13.48% | 11.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.038 | 0.038 | 0.118 | 0.355 | 0.178 | 0.414 |
Dividend Per Share Growth | -67.50% | -67.46% | -66.68% | 99.66% | -57.07% | - |
Dividend Yield | 0.06% | 0.10% | 0.85% | 1.93% | 1.24% | 1.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 528.95 | 136.91 | 59.63 | 37.14 | 36.49 | 32.54 |
Forward PE | 96.58 | 69.06 | 20.34 | 26.92 | - | - |
P/FCF Ratio | - | - | - | - | - | 75.77 |
PS Ratio | 20.96 | 13.30 | 5.04 | 7.03 | 5.86 | 8.56 |